336 related articles for article (PubMed ID: 15569166)
1. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
Huang YW; Saidi P; Philipp C
Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
3. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
4. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
6. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions.
Ng HJ; Tan DC; Lee LH
Haemophilia; 2006 Jul; 12(4):423-8. PubMed ID: 16834745
[TBL] [Abstract][Full Text] [Related]
8. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
[TBL] [Abstract][Full Text] [Related]
9. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
[TBL] [Abstract][Full Text] [Related]
10. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
12. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
13. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature].
Bayani N; Lelong F
Ann Med Interne (Paris); 2001 Apr; 152(3):201-8. PubMed ID: 11431582
[No Abstract] [Full Text] [Related]
14. Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
Hauser I; Gisslinger H; Locker G; Elbl W; Kyrle PA; Pabinger I; Lechner K
Wien Klin Wochenschr; 1993; 105(12):355-8. PubMed ID: 8333206
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
Green D; Rademaker AW; Briët E
Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
[TBL] [Abstract][Full Text] [Related]
17. Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study.
Pardos-Gea J; Altisent C; Parra R; Vilardell-Tarrès M; Ordi-Ros J
Haemophilia; 2012 Sep; 18(5):789-93. PubMed ID: 22429259
[TBL] [Abstract][Full Text] [Related]
18. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
Hertzberg MS; Favaloro E; Koutts J
Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
[No Abstract] [Full Text] [Related]
19. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
Moccia F; Tognoni E; Boccaccio P
Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy prevents recurrent pericarditis.
Marcolongo R; Russo R; Laveder F; Noventa F; Agostini C
J Am Coll Cardiol; 1995 Nov; 26(5):1276-9. PubMed ID: 7594043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
